SAUND SARAN (CHIEF BUSINESS OFFICER) received a stock award from ONCOTELIC THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/16/2021ACC: 0001493152-21-017102
Officer· CHIEF BUSINESS OFFICER
Since Mar 2021
+16.66M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
16.67M acquired · 16.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.35M
Price / share
—
Trade value
—
% of position
New position
3/31/2021
0.00→16.35M
Common Stock
Direct
Shares
+102.52K
Price / share
—
Trade value
—
% of position
0.6%
7/8/2021
16.35M→16.46M
Total
Net shares
+16.46M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2021 | C · Conversion | +16.35M | — | — | New position | 0.00 | 16.35M |
| Common Stock Direct | 7/8/2021 | A · Award | +102.52K | — | — | 0.6% | 16.35M | 16.46M |
| Total | +16.46M | $0.00 | ||||||
Derivative Transactions2
Series A Convertible Preferred Stock
Direct
Converts to
Common Stock
16.35M shares
Shares
−16.36K
Strike price
Held after
0.00
Exercisable
—
3/31/2021
Stock Options
Direct
Converts to
Common Stock
216.28K shares
Shares
+216.28K
Strike price
0.1626
Held after
216.28K
Exercisable
—
7/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Direct | Common Stock16.35M shares | 3/31/2021 | C · Conversion | −16.36K | — | 0.00 | |
| Stock Options Direct | Common Stock216.28K shares | 7/8/2021 | A · Award | +216.28K | 0.1626 | — | 216.28K |